nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—Venous thrombosis—Carboplatin—ocular cancer	0.00986	0.17	CcSEcCtD
Temsirolimus—Extravasation—Carboplatin—ocular cancer	0.0061	0.105	CcSEcCtD
Temsirolimus—Febrile neutropenia—Dactinomycin—ocular cancer	0.00329	0.0566	CcSEcCtD
Temsirolimus—Folliculitis—Dactinomycin—ocular cancer	0.00315	0.0542	CcSEcCtD
Temsirolimus—Extravasation—Dactinomycin—ocular cancer	0.00227	0.039	CcSEcCtD
Temsirolimus—Hypocalcaemia—Dactinomycin—ocular cancer	0.00216	0.0372	CcSEcCtD
Temsirolimus—Infection—Carboplatin—ocular cancer	0.00189	0.0325	CcSEcCtD
Temsirolimus—Mouth ulceration—Dactinomycin—ocular cancer	0.00179	0.0308	CcSEcCtD
Temsirolimus—Sepsis—Dactinomycin—ocular cancer	0.00172	0.0296	CcSEcCtD
Temsirolimus—Pain—Carboplatin—ocular cancer	0.00162	0.028	CcSEcCtD
Temsirolimus—MTOR—Regulation of Telomerase—AKT1—ocular cancer	0.00152	0.00161	CbGpPWpGaD
Temsirolimus—MTOR—Costimulation by the CD28 family—AKT1—ocular cancer	0.00152	0.00161	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDK2—ocular cancer	0.00151	0.0016	CbGpPWpGaD
Temsirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—HRAS—ocular cancer	0.00151	0.0016	CbGpPWpGaD
Temsirolimus—Body temperature increased—Carboplatin—ocular cancer	0.0015	0.0259	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—CDKN1B—ocular cancer	0.0015	0.00159	CbGpPWpGaD
Temsirolimus—MTOR—SREBP signalling—AKT1—ocular cancer	0.0015	0.00159	CbGpPWpGaD
Temsirolimus—MTOR—AMPK Signaling—AKT1—ocular cancer	0.0015	0.00159	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MAML2—ocular cancer	0.00149	0.00158	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—CDKN1A—ocular cancer	0.00147	0.00156	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—MDM2—ocular cancer	0.00146	0.00155	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—MDM2—ocular cancer	0.00146	0.00155	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—MDM2—ocular cancer	0.00146	0.00155	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—MDM2—ocular cancer	0.00144	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—CCND1—ocular cancer	0.00144	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—IRS-mediated signalling—HRAS—ocular cancer	0.00144	0.00153	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—CDKN1B—ocular cancer	0.00143	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—MDM2—ocular cancer	0.00143	0.00152	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—CDKN1B—ocular cancer	0.00143	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDK4—ocular cancer	0.00143	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—MDM2—ocular cancer	0.00142	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—CDKN1B—ocular cancer	0.00142	0.00151	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—CDKN1B—ocular cancer	0.00141	0.0015	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—E2F3—ocular cancer	0.00141	0.0015	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—CDKN1A—ocular cancer	0.00141	0.00149	CbGpPWpGaD
Temsirolimus—MTOR—Leptin signaling pathway—AKT1—ocular cancer	0.0014	0.00149	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.0014	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events—HRAS—ocular cancer	0.0014	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1B—ocular cancer	0.00139	0.00148	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—CDKN1A—ocular cancer	0.00139	0.00147	CbGpPWpGaD
Temsirolimus—MTOR—IRS-related events triggered by IGF1R—HRAS—ocular cancer	0.00138	0.00147	CbGpPWpGaD
Temsirolimus—MTOR—Disease—E2F5—ocular cancer	0.00136	0.00144	CbGpPWpGaD
Temsirolimus—MTOR—IGF1R signaling cascade—HRAS—ocular cancer	0.00135	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—Insulin receptor signalling cascade—HRAS—ocular cancer	0.00135	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—MDM2—ocular cancer	0.00135	0.00143	CbGpPWpGaD
Temsirolimus—MTOR—Disease—E2F4—ocular cancer	0.00133	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)—AKT1—ocular cancer	0.00133	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1B—ocular cancer	0.00133	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—CDKN1B—ocular cancer	0.00133	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—CDKN1B—ocular cancer	0.00133	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—EP300—ocular cancer	0.00133	0.00141	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—CDKN1A—ocular cancer	0.00132	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CDKN1B—ocular cancer	0.00132	0.0014	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—CDKN1A—ocular cancer	0.00132	0.0014	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TFDP1—ocular cancer	0.00131	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—CDKN1A—ocular cancer	0.00131	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RBL1—ocular cancer	0.00131	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RPL39—ocular cancer	0.00131	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CDKN1B—ocular cancer	0.00131	0.00139	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—CDKN1A—ocular cancer	0.0013	0.00138	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—CDKN1B—ocular cancer	0.0013	0.00138	CbGpPWpGaD
Temsirolimus—Aspartate aminotransferase increased—Dactinomycin—ocular cancer	0.00129	0.0223	CcSEcCtD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—MDM2—ocular cancer	0.00129	0.00137	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—CDKN1A—ocular cancer	0.00129	0.00136	CbGpPWpGaD
Temsirolimus—MTOR—CXCR4-mediated signaling events—AKT1—ocular cancer	0.00128	0.00136	CbGpPWpGaD
Temsirolimus—MTOR—MicroRNAs in cardiomyocyte hypertrophy—AKT1—ocular cancer	0.00128	0.00136	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—TP53—ocular cancer	0.00127	0.00135	CbGpPWpGaD
Temsirolimus—MTOR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—ocular cancer	0.00126	0.00133	CbGpPWpGaD
Temsirolimus—Dysphagia—Dactinomycin—ocular cancer	0.00124	0.0214	CcSEcCtD
Temsirolimus—MTOR—Cellular responses to stress—RB1—ocular cancer	0.00124	0.00132	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CDKN1B—ocular cancer	0.00123	0.00131	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—CDKN1A—ocular cancer	0.00123	0.0013	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—CDKN1A—ocular cancer	0.00123	0.0013	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—CDKN1A—ocular cancer	0.00123	0.0013	CbGpPWpGaD
Temsirolimus—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—ocular cancer	0.00122	0.0013	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—CDKN1A—ocular cancer	0.00122	0.00129	CbGpPWpGaD
Temsirolimus—MTOR—Senescence and Autophagy in Cancer—HRAS—ocular cancer	0.00121	0.00129	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—HRAS—ocular cancer	0.00121	0.00129	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—CDKN1A—ocular cancer	0.00121	0.00128	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—CDKN1A—ocular cancer	0.0012	0.00127	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—HRAS—ocular cancer	0.0012	0.00127	CbGpPWpGaD
Temsirolimus—FKBP1A—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.00118	0.00125	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1B—ocular cancer	0.00118	0.00125	CbGpPWpGaD
Temsirolimus—Neutropenia—Dactinomycin—ocular cancer	0.00116	0.02	CcSEcCtD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—MYC—ocular cancer	0.00116	0.00123	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—CDKN1A—ocular cancer	0.00114	0.00121	CbGpPWpGaD
Temsirolimus—CYP3A4—Tryptophan metabolism—MDM2—ocular cancer	0.00113	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—PI-3K cascade—AKT1—ocular cancer	0.00113	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—HRAS—ocular cancer	0.00113	0.0012	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by Insulin receptor—HRAS—ocular cancer	0.00112	0.00119	CbGpPWpGaD
Temsirolimus—Pneumonia—Dactinomycin—ocular cancer	0.00111	0.0192	CcSEcCtD
Temsirolimus—CYP3A5—Metabolism—PSPH—ocular cancer	0.00111	0.00118	CbGpPWpGaD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—EP300—ocular cancer	0.00111	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—PI3K/AKT activation—AKT1—ocular cancer	0.00111	0.00117	CbGpPWpGaD
Temsirolimus—MTOR—GAB1 signalosome—AKT1—ocular cancer	0.0011	0.00116	CbGpPWpGaD
Temsirolimus—Stevens-Johnson syndrome—Dactinomycin—ocular cancer	0.0011	0.0189	CcSEcCtD
Temsirolimus—FKBP1A—Disease—HDAC1—ocular cancer	0.00109	0.00115	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—CDKN1A—ocular cancer	0.00109	0.00115	CbGpPWpGaD
Temsirolimus—Stomatitis—Dactinomycin—ocular cancer	0.00108	0.0186	CcSEcCtD
Temsirolimus—MTOR—Signaling Pathways—SAG—ocular cancer	0.00108	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—ErbB1 downstream signaling—AKT1—ocular cancer	0.00107	0.00114	CbGpPWpGaD
Temsirolimus—MTOR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—ocular cancer	0.00107	0.00114	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN2B—ocular cancer	0.00106	0.00113	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—MDM2—ocular cancer	0.00106	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—VEGFA-VEGFR2 Pathway—AKT1—ocular cancer	0.00106	0.00112	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TFDP1—ocular cancer	0.00105	0.00112	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MAML2—ocular cancer	0.00104	0.00111	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by VEGF—AKT1—ocular cancer	0.000996	0.00106	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—MDM2—ocular cancer	0.000992	0.00105	CbGpPWpGaD
Temsirolimus—Pharyngitis—Dactinomycin—ocular cancer	0.000985	0.017	CcSEcCtD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—E2F1—ocular cancer	0.000976	0.00104	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN2B—ocular cancer	0.000975	0.00104	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1B—ocular cancer	0.000965	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—HRAS—ocular cancer	0.000958	0.00102	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—E2F5—ocular cancer	0.000952	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—TP53—ocular cancer	0.000949	0.00101	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—HRAS—ocular cancer	0.000942	0.001	CbGpPWpGaD
Temsirolimus—Erythema multiforme—Dactinomycin—ocular cancer	0.000939	0.0162	CcSEcCtD
Temsirolimus—MTOR—Signaling Pathways—E2F4—ocular cancer	0.000933	0.000991	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—HRAS—ocular cancer	0.000917	0.000973	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RBL1—ocular cancer	0.000915	0.000971	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GNA11—ocular cancer	0.000909	0.000965	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1B—ocular cancer	0.000906	0.000961	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB4—HRAS—ocular cancer	0.000902	0.000958	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—CDKN1A—ocular cancer	0.000891	0.000946	CbGpPWpGaD
Temsirolimus—Chills—Dactinomycin—ocular cancer	0.000891	0.0153	CcSEcCtD
Temsirolimus—MTOR—Insulin Signaling—HRAS—ocular cancer	0.000866	0.00092	CbGpPWpGaD
Temsirolimus—Erythema—Dactinomycin—ocular cancer	0.000864	0.0149	CcSEcCtD
Temsirolimus—MTOR—Downstream signal transduction—HRAS—ocular cancer	0.000862	0.000915	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—HRAS—ocular cancer	0.000858	0.00091	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—HRAS—ocular cancer	0.000858	0.00091	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—HRAS—ocular cancer	0.000853	0.000906	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—HRAS—ocular cancer	0.000849	0.000902	CbGpPWpGaD
Temsirolimus—MTOR—Cellular responses to stress—EP300—ocular cancer	0.000848	0.0009	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by SCF-KIT—AKT1—ocular cancer	0.000846	0.000898	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—GNAQ—ocular cancer	0.000845	0.000897	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDK2—ocular cancer	0.000842	0.000894	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—HRAS—ocular cancer	0.000837	0.000889	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MAML2—ocular cancer	0.000837	0.000888	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PSPH—ocular cancer	0.000836	0.000888	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—CDKN1A—ocular cancer	0.000836	0.000887	CbGpPWpGaD
Temsirolimus—ABCB1—Allograft Rejection—TGFB1—ocular cancer	0.000833	0.000884	CbGpPWpGaD
Temsirolimus—MTOR—BDNF signaling pathway—AKT1—ocular cancer	0.000832	0.000883	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling of activated FGFR—AKT1—ocular cancer	0.00081	0.00086	CbGpPWpGaD
Temsirolimus—MTOR—Integrated Breast Cancer Pathway—AKT1—ocular cancer	0.000801	0.00085	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—HRAS—ocular cancer	0.000799	0.000848	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—HRAS—ocular cancer	0.000799	0.000848	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—HRAS—ocular cancer	0.000799	0.000848	CbGpPWpGaD
Temsirolimus—Anaemia—Dactinomycin—ocular cancer	0.000799	0.0138	CcSEcCtD
Temsirolimus—MTOR—Signaling by ERBB4—AKT1—ocular cancer	0.000797	0.000846	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—ocular cancer	0.000796	0.000845	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—E2F3—ocular cancer	0.000793	0.000842	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR—HRAS—ocular cancer	0.000792	0.000841	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PSPH—ocular cancer	0.000788	0.000837	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—HRAS—ocular cancer	0.000785	0.000833	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by PDGF—HRAS—ocular cancer	0.000781	0.000829	CbGpPWpGaD
Temsirolimus—Leukopenia—Dactinomycin—ocular cancer	0.000774	0.0133	CcSEcCtD
Temsirolimus—MTOR—Insulin Signaling—AKT1—ocular cancer	0.000765	0.000812	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HDAC1—ocular cancer	0.000762	0.000809	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signal transduction—AKT1—ocular cancer	0.000761	0.000808	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR—AKT1—ocular cancer	0.000757	0.000804	CbGpPWpGaD
Temsirolimus—MTOR—EGF/EGFR Signaling Pathway—AKT1—ocular cancer	0.000757	0.000804	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by ERBB2—AKT1—ocular cancer	0.000754	0.0008	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 signaling—AKT1—ocular cancer	0.00075	0.000796	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—HRAS—ocular cancer	0.000739	0.000785	CbGpPWpGaD
Temsirolimus—MTOR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—ocular cancer	0.000739	0.000785	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TFDP1—ocular cancer	0.000738	0.000783	CbGpPWpGaD
Temsirolimus—Myalgia—Dactinomycin—ocular cancer	0.000736	0.0127	CcSEcCtD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—HRAS—ocular cancer	0.000708	0.000751	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by FGFR in disease—AKT1—ocular cancer	0.000705	0.000749	CbGpPWpGaD
Temsirolimus—MTOR—DAP12 interactions—AKT1—ocular cancer	0.000705	0.000749	CbGpPWpGaD
Temsirolimus—MTOR—Fc epsilon receptor (FCERI) signaling—AKT1—ocular cancer	0.000705	0.000749	CbGpPWpGaD
Temsirolimus—Oedema—Dactinomycin—ocular cancer	0.000705	0.0122	CcSEcCtD
Temsirolimus—Infection—Dactinomycin—ocular cancer	0.000701	0.0121	CcSEcCtD
Temsirolimus—MTOR—Signaling by EGFR—AKT1—ocular cancer	0.000699	0.000742	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by EGFR in Cancer—AKT1—ocular cancer	0.000693	0.000736	CbGpPWpGaD
Temsirolimus—Thrombocytopenia—Dactinomycin—ocular cancer	0.000691	0.0119	CcSEcCtD
Temsirolimus—MTOR—Signaling by PDGF—AKT1—ocular cancer	0.00069	0.000732	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN2B—ocular cancer	0.000683	0.000725	CbGpPWpGaD
Temsirolimus—Anorexia—Dactinomycin—ocular cancer	0.000672	0.0116	CcSEcCtD
Temsirolimus—ABCB1—HIF-1-alpha transcription factor network—AKT1—ocular cancer	0.000669	0.00071	CbGpPWpGaD
Temsirolimus—MTOR—B Cell Activation—AKT1—ocular cancer	0.000653	0.000693	CbGpPWpGaD
Temsirolimus—Musculoskeletal discomfort—Dactinomycin—ocular cancer	0.000643	0.0111	CcSEcCtD
Temsirolimus—FKBP1A—Signaling Pathways—E2F1—ocular cancer	0.000627	0.000665	CbGpPWpGaD
Temsirolimus—MTOR—NGF signalling via TRKA from the plasma membrane—AKT1—ocular cancer	0.000625	0.000663	CbGpPWpGaD
Temsirolimus—Decreased appetite—Dactinomycin—ocular cancer	0.000613	0.0106	CcSEcCtD
Temsirolimus—MTOR—Disease—HDAC1—ocular cancer	0.000612	0.000649	CbGpPWpGaD
Temsirolimus—Fatigue—Dactinomycin—ocular cancer	0.000608	0.0105	CcSEcCtD
Temsirolimus—MTOR—Cellular responses to stress—TP53—ocular cancer	0.000607	0.000644	CbGpPWpGaD
Temsirolimus—Pain—Dactinomycin—ocular cancer	0.000603	0.0104	CcSEcCtD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MDM2—ocular cancer	0.00059	0.000626	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MAML2—ocular cancer	0.000586	0.000622	CbGpPWpGaD
Temsirolimus—Gastrointestinal pain—Dactinomycin—ocular cancer	0.000577	0.00994	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—MDM2—ocular cancer	0.000566	0.000601	CbGpPWpGaD
Temsirolimus—Body temperature increased—Dactinomycin—ocular cancer	0.000558	0.00961	CcSEcCtD
Temsirolimus—Abdominal pain—Dactinomycin—ocular cancer	0.000558	0.00961	CcSEcCtD
Temsirolimus—MTOR—Disease—CDKN2B—ocular cancer	0.000548	0.000582	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—HRAS—ocular cancer	0.000544	0.000578	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—MDM2—ocular cancer	0.000543	0.000577	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MDM2—ocular cancer	0.000541	0.000574	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—ocular cancer	0.000538	0.000572	CbGpPWpGaD
Temsirolimus—Hypersensitivity—Dactinomycin—ocular cancer	0.00052	0.00895	CcSEcCtD
Temsirolimus—MTOR—Innate Immune System—CDKN1B—ocular cancer	0.000517	0.000548	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PSPH—ocular cancer	0.000515	0.000547	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—ocular cancer	0.000514	0.000545	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNA11—ocular cancer	0.000511	0.000543	CbGpPWpGaD
Temsirolimus—Asthenia—Dactinomycin—ocular cancer	0.000506	0.00872	CcSEcCtD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—ocular cancer	0.000497	0.000528	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1B—ocular cancer	0.000496	0.000527	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1B—ocular cancer	0.000494	0.000524	CbGpPWpGaD
Temsirolimus—Diarrhoea—Dactinomycin—ocular cancer	0.000483	0.00831	CcSEcCtD
Temsirolimus—CYP3A7—Metabolism—GNA11—ocular cancer	0.000483	0.000512	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—AKT1—ocular cancer	0.000481	0.00051	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—CDKN1A—ocular cancer	0.000477	0.000506	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—GNAQ—ocular cancer	0.000475	0.000505	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—ocular cancer	0.000473	0.000502	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—CDKN1A—ocular cancer	0.000458	0.000486	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—CDKN1A—ocular cancer	0.000456	0.000484	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EP300—ocular cancer	0.000454	0.000482	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GNAQ—ocular cancer	0.000449	0.000476	CbGpPWpGaD
Temsirolimus—Vomiting—Dactinomycin—ocular cancer	0.000448	0.00773	CcSEcCtD
Temsirolimus—Rash—Dactinomycin—ocular cancer	0.000445	0.00766	CcSEcCtD
Temsirolimus—FKBP1A—Disease—EP300—ocular cancer	0.000434	0.00046	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HDAC1—ocular cancer	0.000428	0.000455	CbGpPWpGaD
Temsirolimus—Nausea—Dactinomycin—ocular cancer	0.000419	0.00722	CcSEcCtD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—ocular cancer	0.000412	0.000437	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—ocular cancer	0.000411	0.000436	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN2B—ocular cancer	0.000384	0.000408	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MDM2—ocular cancer	0.000379	0.000402	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—ocular cancer	0.000378	0.000401	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—TGFB1—ocular cancer	0.000377	0.0004	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—E2F1—ocular cancer	0.000352	0.000374	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GNA11—ocular cancer	0.000349	0.00037	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1B—ocular cancer	0.000346	0.000367	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—ocular cancer	0.000338	0.000359	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CCND1—ocular cancer	0.00033	0.00035	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MDM2—ocular cancer	0.000329	0.00035	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GNAQ—ocular cancer	0.000324	0.000344	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CDKN1A—ocular cancer	0.000319	0.000339	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—HRAS—ocular cancer	0.00031	0.00033	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MDM2—ocular cancer	0.000304	0.000323	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EP300—ocular cancer	0.000304	0.000322	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1B—ocular cancer	0.000301	0.000319	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—HRAS—ocular cancer	0.000298	0.000316	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—HRAS—ocular cancer	0.000297	0.000315	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—ocular cancer	0.000286	0.000303	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1B—ocular cancer	0.000278	0.000295	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CDKN1A—ocular cancer	0.000278	0.000295	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—ocular cancer	0.000274	0.000291	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—ocular cancer	0.000265	0.000281	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EP300—ocular cancer	0.000264	0.00028	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TGFB1—ocular cancer	0.000264	0.00028	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GNA11—ocular cancer	0.000263	0.000279	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—ocular cancer	0.000263	0.000279	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—ocular cancer	0.000262	0.000278	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CDKN1A—ocular cancer	0.000256	0.000272	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GNA11—ocular cancer	0.000248	0.000263	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GNAQ—ocular cancer	0.000245	0.00026	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EP300—ocular cancer	0.000244	0.000259	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GNAQ—ocular cancer	0.000231	0.000245	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—ocular cancer	0.000217	0.000231	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MDM2—ocular cancer	0.000213	0.000226	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—ocular cancer	0.000213	0.000226	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TGFB1—ocular cancer	0.000212	0.000225	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—HRAS—ocular cancer	0.000208	0.000221	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1B—ocular cancer	0.000195	0.000206	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CCND1—ocular cancer	0.000186	0.000197	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—ocular cancer	0.000184	0.000195	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—HRAS—ocular cancer	0.000181	0.000192	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN1A—ocular cancer	0.00018	0.000191	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EP300—ocular cancer	0.000171	0.000181	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HRAS—ocular cancer	0.000167	0.000177	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GNA11—ocular cancer	0.000162	0.000172	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—EP300—ocular cancer	0.000161	0.000171	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—ocular cancer	0.00016	0.000169	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GNAQ—ocular cancer	0.000151	0.00016	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—ocular cancer	0.000149	0.000158	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TGFB1—ocular cancer	0.000148	0.000158	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—ocular cancer	0.000147	0.000156	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—ocular cancer	0.000122	0.00013	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HRAS—ocular cancer	0.000117	0.000124	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—EP300—ocular cancer	0.000117	0.000124	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—ocular cancer	0.000103	0.00011	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—ocular cancer	9.74e-05	0.000103	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—EP300—ocular cancer	8.79e-05	9.34e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—EP300—ocular cancer	8.29e-05	8.8e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—ocular cancer	7.04e-05	7.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—EP300—ocular cancer	5.42e-05	5.75e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—ocular cancer	5.31e-05	5.64e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—ocular cancer	5.01e-05	5.32e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—ocular cancer	3.27e-05	3.48e-05	CbGpPWpGaD
